• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于精确估计肝脏消除轴向扩散模型参数的最优实验设计。

Optimal experimental design for precise estimation of the parameters of the axial dispersion model of hepatic elimination.

作者信息

Chou C H, Aarons L, Rowland M

机构信息

School of Pharmacy and Pharmaceutical Sciences, University of Manchester, United Kingdom.

出版信息

J Pharmacokinet Biopharm. 1998 Oct;26(5):595-615. doi: 10.1023/a:1023229318017.

DOI:10.1023/a:1023229318017
PMID:10205773
Abstract

The axial dispersion model of hepatic drug elimination is characterized by two dimensionless parameters, the dispersion number, DN, and the efficiency number, RN, corresponding to the relative dispersion of material on transit through the organ and the relative efficiency of elimination of drug by the organ, respectively. Optimal design theory was applied to the estimation of these two parameters based on changes in availability (F) of drug at steady state for the closed boundary condition model, with particular attention to variations in the fraction of drug unbound in the perfusate (fuB). Sensitivity analysis indicates that precision in parameter estimation is greatest when F is low and that correlation between RN and DN is high, which is desirable for parameter estimation, when DN lies between 0.1 and 100. Optimal design points were obtained using D-optimization, taking into account the error variance model. If the error variance model is unknown, it is shown that choosing Poisson error model is reasonable. Furthermore, although not optimal, geometric spacing of fuB values is often reasonable and definitively superior to a uniform spacing strategy. In practice, the range of fuB available for selection may be limited by such practical considerations as assay sensitivity and acceptable concentration range of binding protein. Notwithstanding, optimal design theory provides a rational approach to precise parameter estimation.

摘要

肝脏药物消除的轴向弥散模型由两个无量纲参数表征,即弥散数(DN)和效率数(RN),分别对应物质在器官中转运时的相对弥散以及器官对药物的相对消除效率。基于封闭边界条件模型稳态下药物可用性(F)的变化,将最优设计理论应用于这两个参数的估计,特别关注灌注液中游离药物分数(fuB)的变化。敏感性分析表明,当F较低时,参数估计的精度最高;当DN在0.1至100之间时,RN与DN之间的相关性较高,这对于参数估计是有利的。考虑误差方差模型,使用D优化获得最优设计点。如果误差方差模型未知,结果表明选择泊松误差模型是合理的。此外,尽管不是最优的,但fuB值的几何间距通常是合理的,并且肯定优于均匀间距策略。在实践中,可供选择的fuB范围可能受到诸如分析灵敏度和结合蛋白可接受浓度范围等实际因素的限制。尽管如此,最优设计理论为精确的参数估计提供了一种合理的方法。

相似文献

1
Optimal experimental design for precise estimation of the parameters of the axial dispersion model of hepatic elimination.用于精确估计肝脏消除轴向扩散模型参数的最优实验设计。
J Pharmacokinet Biopharm. 1998 Oct;26(5):595-615. doi: 10.1023/a:1023229318017.
2
Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver.肝药物消除轴向扩散模型在离体灌注大鼠肝脏中地西泮动力学的应用。
J Pharmacokinet Biopharm. 1992 Apr;20(2):171-93. doi: 10.1007/BF01071000.
3
Influence of albumin on the distribution and elimination kinetics of diclofenac in the isolated perfused rat liver: analysis by the impulse-response technique and the dispersion model.白蛋白对双氯芬酸在离体灌注大鼠肝脏中分布及消除动力学的影响:脉冲响应技术和弥散模型分析
J Pharm Sci. 1993 Apr;82(4):421-8. doi: 10.1002/jps.2600820417.
4
Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.用扩展对流扩散模型对肝脏消除和器官分布动力学进行建模。
J Pharmacokinet Biopharm. 1999 Aug;27(4):343-82. doi: 10.1023/a:1020992421184.
5
Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models.血浆蛋白结合对离体灌注大鼠肝脏消除牛磺胆酸盐的影响:静脉平衡、非分布和分布性肝血窦以及弥散模型的比较
J Pharmacokinet Biopharm. 1988 Aug;16(4):377-96. doi: 10.1007/BF01062552.
6
A two-compartment dispersion model describes the hepatic outflow profile of diclofenac in the presence of its binding protein.双室分散模型描述了双氯芬酸在其结合蛋白存在时的肝流出曲线。
J Pharm Pharmacol. 1991 Oct;43(10):709-14. doi: 10.1111/j.2042-7158.1991.tb03463.x.
7
Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT).用于通过快速拉普拉斯逆变换(FILT)分析药物器官灌注系统的双室弥散模型。
J Pharmacokinet Biopharm. 1989 Apr;17(2):179-202. doi: 10.1007/BF01059027.
8
Optimal experiment design for cardinal values estimation: guidelines for data collection.基数估计的最优实验设计:数据收集指南
Int J Food Microbiol. 2005 Apr 15;100(1-3):153-65. doi: 10.1016/j.ijfoodmicro.2004.10.012. Epub 2005 Jan 6.
9
On the validity of the dispersion model of hepatic drug elimination when intravascular transit time densities are long-tailed.当血管内转运时间密度呈长尾分布时肝药物消除弥散模型的有效性
Bull Math Biol. 1997 Sep;59(5):911-29. doi: 10.1007/BF02459999.
10
Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.在缺乏白蛋白的情况下从体外推导出药物的肝脏清除率,到体内存在白蛋白的情况下:基于白蛋白介导的肝摄取理论的 2 种外推模型的比较评估及其局限性和机制见解。
J Pharm Sci. 2018 Jul;107(7):1791-1797. doi: 10.1016/j.xphs.2018.03.012. Epub 2018 Mar 20.

引用本文的文献

1
Modeling kinetics of subcellular disposition of chemicals.化学物质亚细胞分布动力学建模。
Chem Rev. 2009 May;109(5):1793-899. doi: 10.1021/cr030440j.
2
Whole body pharmacokinetic models.全身药代动力学模型。
Clin Pharmacokinet. 2003;42(10):883-908. doi: 10.2165/00003088-200342100-00002.

本文引用的文献

1
Physiologic models of hepatic drug clearance: influence of altered protein binding on the elimination of diclofenac in the isolated perfused rat liver.肝脏药物清除的生理模型:蛋白结合改变对离体灌注大鼠肝脏中双氯芬酸消除的影响。
J Pharm Sci. 1993 Sep;82(9):880-5. doi: 10.1002/jps.2600820904.
2
Design and optimization of tracer experiments in physiology and medicine.生理学与医学中示踪实验的设计与优化
Fed Proc. 1980 Jan;39(1):84-90.
3
Optimal sampling times for pharmacokinetic experiments.药代动力学实验的最佳采样时间。
J Pharmacokinet Biopharm. 1981 Dec;9(6):739-56. doi: 10.1007/BF01070904.
4
Optimal design of experiments for the estimation of precise hyperbolic kinetic and binding parameters.用于精确估计双曲线动力学和结合参数的实验的优化设计。
J Theor Biol. 1981 May 21;90(2):241-63. doi: 10.1016/0022-5193(81)90045-x.
5
Flow dependence of propranolol elimination in perfused rat liver.
J Pharmacol Exp Ther. 1984 Aug;230(2):474-7.
6
The problem of choosing weights in nonlinear regression analysis of pharmacokinetic data.药代动力学数据非线性回归分析中权重选择的问题。
Drug Metab Rev. 1984;15(1-2):133-48. doi: 10.3109/03602538409015060.
7
Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.通过普萘洛尔蛋白结合的扰动来区分离体灌注大鼠肝脏中肝药物消除的静脉平衡模型和窦状隙模型。
J Pharmacol Exp Ther. 1984 May;229(2):522-6.
8
Albumin binding and hepatic uptake: the importance of model selection.
J Pharm Sci. 1983 Oct;72(10):1232-3. doi: 10.1002/jps.2600721038.
9
Hepatic extraction of free fatty acids in pregnant and nonpregnant female rats.
J Pharm Sci. 1983 Oct;72(10):1230-2. doi: 10.1002/jps.2600721037.
10
Models of hepatic drug elimination.
J Pharm Sci. 1983 Oct;72(10):1229-30. doi: 10.1002/jps.2600721035.